COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

In conclusion, during the COVID-19 pandemic, due to the key roles of cytokines in the promotion of the disease, the rheumatic patients may benefit from continuing their previous treatment, which may have protective effects.PMID:33213130 | DOI:10.4081/reumatismo.2020.1289

Source: Reumatismo - November 20, 2020 Category: Rheumatology Authors: Z Ahmadinejad R Assari N Ayoobi Yazdi S-H Mazloomi P Javanshayani H Khalili Afousi V Ziaee Source Type: research